Palatable Support Compositions for Veterinary Medication
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current palatable support compositions for veterinary medication, particularly for cats, face challenges in storage stability due to interactions between components, leading to a reduction in therapeutic activity of embedded active substances, and there is a lack of understanding about specific compounds responsible for palatability in feline nutrition.
Innovation Solution
The development of palatable support compositions containing 20-40% humectant plasticizer, 0.5-8% gelling agents, and 20-50% protein on a dry matter basis, with a moisture content of 20-35%, which can incorporate medicinal products and have a trapezoidal cylindrical shape, providing good moldability and chewiness, and including ingredients like glycerin, gum Arabic, and yeast extract to enhance palatability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If active substances are embedded within a palatable matrix, then palatability is improved, but storage stability deteriorates due to physical and chemical interactions between matrix components and active substances
Solution Approach 1:
The patent introduces a protective coating or barrier layer between the active substance and the palatable matrix components. This intermediary prevents direct contact and interaction between water/hygroscopic ingredients in the matrix and the active substance, thereby maintaining storage stability while preserving palatability. The coating acts as a mediator that allows the system to benefit from both embedding (palatability) and isolation (stability).
Solution Approach 2:
The patent creates different zones within the composition: an outer palatable matrix region and an inner protected active substance region. By applying local quality differentiation through selective coating or spatial arrangement, the palatable components can interact with the animal while the active substance remains isolated from degrading interactions, thus resolving the contradiction between overall palatability and localized stability.
2Ease of operation
If a palatable support with high moisture content is used, then chewiness and moldability are improved, but storage stability deteriorates due to increased interaction between water and active substances
Solution Approach 1:
The protective coating serves as a moisture barrier that mediates between the high-moisture palatable support and the active substance. This allows the support to maintain high moisture content for desirable chewiness and moldability while the coating prevents water from reaching and interacting with the active substance, thus preserving storage stability despite the high moisture environment.
3Ease of operation
If hygroscopic ingredients are added to enhance palatability, then ease of ingestion is improved, but storage stability deteriorates due to increased water attraction and interaction with active substances
Solution Approach 1:
The protective coating acts as a barrier that prevents hygroscopic ingredients from attracting and transporting water to the active substance. This intermediary layer allows hygroscopic ingredients to be present in the matrix for enhanced palatability and ease of ingestion while blocking their water-attracting effect from reaching the active substance, thus maintaining storage stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed compositions effectively administer medicinal products to cats, offering improved palatability and stability, ensuring the therapeutic activity of embedded substances and addressing the complexity of feline palatability preferences.
Implementation Method 1
from about 20% to about 40% by weight of a humectant plasticizer
Implementation Method 2
from about 0.5% to about 8% by weight of one or more gelling agents
Data Source
AI summary
The presently disclosed subject matter relates to palatable support compositions for administering one or more medicinal products to an animal, for example, a feline. The palatable support compositions include (i) from about 20% to about 40% by weight of a humectant plasticizer; (ii) from about 0.5% to about 8% by weight of one or more gelling agents; and (iii) from about 20% to about 50% by weight of protein, on a dry matter basis. The present disclosure further provides methods for preparing and use of such palatable support compositions.